Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Rectal Neoplasms 11Glioblastoma 10Breast Neoplasms 10Lung Neoplasms 9Head and Neck Neoplasms 8Neoplasms 6Neoplasm Metastasis 6Brain Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Prostatic Neoplasms 5Leukemia 4Gliosarcoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Carcinoma, Merkel Cell 3Adenocarcinoma Of Esophagus 3Xerostomia 2Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2

Interventions

Temozolomide 3Panobinostat 2Cyclophosphamide 2Bevacizumab 2ribociclib 1marizomib 1dipinacoline glutamate 1cemiplimab 1Topotecan 1TIC10 compound 1Re-Irradiation 1Radiotherapy 1Radiation 1Maintenance 1Irinotecan 1Imiquimod 1Granulocyte-Macrophage Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Drug Tolerance 1Doxorubicin 1Diphtheria-Tetanus Vaccine 1Congresses as Topic 1Cilengitide 1Cetuximab 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Diffuse Intrinsic Pontine Glioma × Radiation × Clear all
NCT01182350 2019-09-04

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Dana-Farber Cancer Institute

Phase 2 Terminated
53 enrolled 12 charts
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡